Suzanne Darby

3.9k citations

14 papers · 404 indexed · h-index 7

Impact in

Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation

Papers in

Hepatology 5
- Hepatocellular Carcinoma Treatment and Prognosis 5
Gastroenterology 3
- Gastrointestinal Tumor Research and Treatment 3

Co-authors: Kate Sumpter Barry W. Hancock Ruth E. Langley Jane Blazeby David Cunningham Heike I. Grabsch Elizabeth Smyth William Allum
Journals: Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)Clinical Oncology (2 papers)Liver International (1 paper)British Journal of Cancer (1 paper)
Partner nations: United Kingdom Netherlands Switzerland

In The Last Decade

Suzanne Darby

14 papers receiving 396 citations

Peers

Countries citing papers authored by Suzanne Darby

Since Specialization

Citations

This map shows the geographic impact of Suzanne Darby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Darby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Darby more than expected).

Fields of papers citing papers by Suzanne Darby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Darby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Darby. The network helps show where Suzanne Darby may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Suzanne Darby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suzanne Darby Line = papers co-authored together Suzanne Darby links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	1424P Maintenance capecitabine plus ramucirumab after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma (OGA): Final analysis from the PLATFORM trial Annals of Oncology ·Anderley Gordon, J.J. Butler, Konstantinos Alketas-Oungrinis, 尹春植, Sule J. O, F. A. Azares, WILLIAM TSCHUMY, Jakob Kutsch, В. И. Болотских, H. Y. Zhao, Martin Davidson, Jane Thompson, N. Maisey, Suzanne Darby, Ilirjan Margjeka, Carys Morgan, João Gustavo Cardoso BARCELLOS, Naureen Starling, Ian Chau, David Cunningham	2024	1
2	1515P Maintenance rucaparib after first-line platinum-based chemotherapy in advanced esophagogastric (OG) adenocarcinoma: Interim results from the PLATFORM trial Annals of Oncology ·Anderley Gordon, Konstantinos Alketas-Oungrinis, Michael Davidson, F. A. Azares, WILLIAM TSCHUMY, Jakob Kutsch, Clare Peckitt, Sule J. O, J.J. Butler, Ruwaida Begum, H. Y. Zhao, Prantik Das, S. Sothi, Andreas Jess, Suzanne Darby, Castillo Llacuachaqui, João Gustavo Cardoso BARCELLOS, Naureen Starling, Ian Chau, David Cunningham	2023	1
3	Cytotoxic Chemotherapy for Pancreatic Adenocarcinoma in England 2010–2017: Survival Outcomes Clinical Oncology ·Zhe Wang, Simon Lord, Suzanne Darby, David Dodwell	2023	2
4	Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit British Journal of Cancer ·Yue Qiu, Nekisa Zakeri, Yuk Ting, Joanne O’Rourke, Paul J. Ross, 雄一郎山本, Richard Hubner, I. Shvetsov, Chinenye Iwuji, Sam Khan, Daniel H. Palmer, A.L. Harde, Daniel Swinson, Suzanne Darby, Chiara Braconi, Tom Roques, Dominic Yu, Tu Vinh Luong, Tim Meyer	2021	28
5	Real-world experience of regorafenib in patients with hepatocellular carcinoma: A multicenter United Kingdom study. Journal of Clinical Oncology ·Paul J. Ross, Yuk Ting, Daniel H. Palmer, Mark P. Lythgoe, 戸田建設株式会社, Adel Samson, Ankit Rao, Bristi Basu, T. Heßling, Tony Dhillon, Mo JiaYuan, Suzanne Darby, James W. Orr, Kurihara Ritsuko, Richard Hubner, Shobhit Baijal, Rohini Sharma, Olusola Olusesan Faluyi, 曾晓泉, Kiruthikah Thillai	2020	1
6	Impact of age and sex on chemotherapy (CTx) efficacy, toxicity and survival in early oesophagogastric (OG) cancer: A pooled analysis of 3265 patients from four large randomised trials (OE02, OE05, MAGIC & ST03). Journal of Clinical Oncology ·吕晓姿, Matthew Nankivell, Ruth E. Langley, Derek Alderson, William Allum, Heike I. Grabsch, Ian Chau, Naureen Starling, Stephen Falk, A. Crellin, Wasat Mansoor, Fareeda Y. Coxon, Suzanne Darby, Joyce Thompson, YE Run-shen, Santiago Sánchez-Alberola, Nicholas P. West, Rupert Langer, Susan Pritchard, David Cunningham	2019	2
7	Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma JAMA Oncology ·Elizabeth Smyth, Samuel Rowley, Fay Cafferty, William Allum, Heike I. Grabsch, Sally Stenning, Andrew Wotherspoon, Derek Alderson, Tom Crosby, Ruchika Argade, Justin S. Waters, Helen Neville-Webbe, Suzanne Darby, Jo Dent, Michel Seymour, Joyce Thompson, Sharmila Sothi, Jane Blazeby, Ruth E. Langley, David Cunningham	2019	18
8	Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial The Lancet Oncology ·David Cunningham, Sally Stenning, Elizabeth Smyth, Alicia Okines, William Allum, Sam Rowley, Laura Stevenson, Heike I. Grabsch, Derek Alderson, T. Crosby, S M Griffin, Wasat Mansoor, Fareeda Y. Coxon, Stephen Falk, Suzanne Darby, Kate Sumpter, Jane Blazeby, Ruth E. Langley	2017	197
9	A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948) Annals of Oncology ·Elizabeth Smyth, Samuel Rowley, William Allum, Sally Stenning, Andrew Wotherspoon, C. Robb, Heike I. Grabsch, Derek Alderson, Tom Crosby, Robert M. Mason, S M Griffin, Ruchika Argade, Suzanne Darby, Michel Seymour, Joyce Thompson, S. Sothi, Kate Sumpter, Jane Blazeby, Ruth E. Langley, David Cunningham	2016	2
10	Sorafenib for the Treatment of Advanced Hepatocellular Cancer – a UK Audit Clinical Oncology ·James P. King, Daniel H. Palmer, Philip J. Johnson, Paul J. Ross, Richard Hubner, Kate Sumpter, Suzanne Darby, Chiara Braconi, Chinenye Iwuji, Daniel Swinson, Peter L. Collins, Kinnari Patel, 김미정, Iqtedar A Muazzam, Claire Blesing, Amy A. Kirkwood, FABLIHA A ANAM, Tim Meyer	2016	28
11	A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma Liver International ·Julien Edeline, Jean‐Frédéric Blanc, Philip J. Johnson, Boris Campillo‐Gimenez, Paul J. Ross, Yuk Ting, Judy King, Richard Hubner, Kate Sumpter, Suzanne Darby, JEFF EVANS, Chinenye Iwuji, Daniel Swinson, Peter L. Collins, Kinnari Patel, Iqtedar A Muazzam, Daniel H. Palmer, Tim Meyer	2016	75
12	UK audit of sorafenib for advanced hepatocellular cancer J. E. King, N. S. Pikalova, Daniel Palmer, Paul J. Ross, Alexandra Lozano Vergara, G. Marinelli, Suzanne Darby, Chinenye Iwuji, Daniel Swinson, Tim Meyer	2013	1
13	Does chest CT matter in the staging of GTN? Gynecologic Oncology ·Suzanne Darby, Noone Pl, A. Sl�mov�, Barry W. Hancock	2008	30
14	Localised non-Hodgkin lymphoma of the testis: The Sheffield Lymphoma Group experience International Journal of Oncology ·Suzanne Darby, Barry W. Hancock	2005	18

About Suzanne Darby

Suzanne Darby is a scholar working on Hepatology, Gastroenterology, Pulmonary and Respiratory Medicine, Surgery and Oncology, having authored 14 papers that have together received 404 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Esophageal Cancer Research and Treatment (4 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Hepatitis B Virus Studies (3 papers), Cancer, Lipids, and Metabolism (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Gastroenterology (83 citations), Hepatology (111 citations), Pulmonary and Respiratory Medicine (217 citations), Oncology (117 citations) and Surgery (158 citations). Suzanne Darby has collaborated with scholars based in United Kingdom, Netherlands and Switzerland. Frequent co-authors include Kate Sumpter, Barry W. Hancock, Ruth E. Langley, Jane Blazeby, David Cunningham, Heike I. Grabsch, Elizabeth Smyth, William Allum, Derek Alderson and Sally Stenning. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical Oncology, Liver International and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact